flourishresearch.com

Flourish Research

Weight Management Self-Scheduler

Basic Criteria 

  • Are you 18-65? 
  • Do one of the following apply: 
    • Is your BMI ≥30 to ≤45 kg/m2? Calculate here
    • Is your BMI ≥27 to <30 kg/m2 with the presence of 1 or more weight-related comorbid conditions such as high blood pressure, high cholesterol or prediabetes? Calculate here

Answers Must Be No 

  • Are you pregnant or breastfeeding? 
  • Do you have a history of Type 1 or active Type 2 diabetes? If T2D has it been resolved at least 12 months? 
  • Do you have uncontrolled psychiatric disease including major depressive disorder, bipolar, anxiety disorder or eating disorders like bulimia or binge-eating? 
  • Are you taking or have recently taken any weight loss or diabetic medications?
  • Do you have any liver disease such as NAFLD, NASH or cirrhosis? 
  • Do you have Chronic Kidney Disease? 
  • Do you smoke cigarettes or marijuana, vape or smoke cigars? 
  • Do you have any chronic orthopedic disease that prevent you from walking? 
  • Do you have a history of cardiovascular disease? 
  • Do you have active cancer (other than local squamous cell and basal cell carcinoma?) 
  • Do you have a history of trans ischemic attack, cerebrovascular accident (brain attack) or brain aneurysm? 
  • Do you have a history of or active peripheral vascular disease such as deep vein thrombosis, pulmonary embolism, chronic venous insufficiency, claudication or lymphedema? 
  • Do you have a history of moderate-to-severe sleep apnea, moderate to severe asthma, chronic obstructive pulmonary disease (COPD) or pulmonary fibrosis? 
  • Have you had immunosuppressive, chemotherapeutic or radiation in the past 12 months? 
  • Have you used any anti-diabetic medications, nutritional supplements or over-the-counter products for lowering blood sugar or weight loss in the past 3 months? 
  • Have you had bariatric surgery, gastric or peptic ulcer, active gastritis or esophagitis or uncontrolled gastroesophageal reflux disease (GERD) or severe inflammatory bowel disease? 
  • Have you been in a study with investigational drug in the past 3 months? 
  • Do you use any medication that may increase your weight such as anti-convulsant or psychotropic medications in the past 3 months? (ex: risperidone, olanzapine, quetiapine, gabapentin, pregabalin, valproic acid, and vigabatrin) 
  • Do you have any active infection or recent treatment in the past 6 months for HIV, Hepatitis B or C, tuberculosis or Long COVID? 
  • Do you have uncontrolled thyroid disease? 
  • Do you have a history of severe endocrine disorders such as Cushing’s disease, hypogonadism or growth hormone deficiency? 
  • Do you have a history of autoimmune/inflammatory disorders such as myasthenia gravis, rheumatoid arthritis, lupus, polymyositis or dermatomyositis? 
  • Do you have a history of acute or chronic pancreatitis or have untreated high triglycerides ≥500? 
  • Do you have a history of alcoholism or illegal drug use? 

 

Answers Must Be Yes 

  • If female of childbearing potential, do you agree to use one or more highly effective methods of contraception until 20 weeks after the last study dose? 
  • If female of childbearing potential and you use hormonal contraception are you willing to switch to a non-oral contraception method and/or ad a barrier method of contraception up to 4 weeks after each dose? 
  • Have you tried at least once to diet to lose weight? 
  • Has your body weight been the same for the past 90 days (not lost or gained 11 pounds) 
  • Are you able to receive drug infusions via IV and provide blood samples? 
  • If you have high blood pressure, is it controlled?
  • Are you able to walk without assistance of a walker, cane or crutches?

 

  • Additional criteria will apply

PLEASE NOTE: Please confirm your eligibility before your appointment by calling 210-714-0067.

If you do not see an available appointment, please call 210-714-0067.

Transportation may be available. Call 210-714-0067. Compensation up to $3,076 is available for time and travel.

 

Schedule Appointment
Flourish Research News

Stay current with the latest clinical trial news and learn how Flourish Research is supporting the advancement of life-changing therapeutics.

Exciting News! ENCORE™ is now part of the Flourish family!